United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE276.7300
- TODAY'S CHANGE (%)3.5400 (1.2958%)
- Bid / Lots276.4000/ 1
- Ask / Lots299.9400/ 1
- Open / Previous Close274.0500 / 273.1900
- Day Range
- 52 Week Range
- Volume367,135
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 12429 | 273.195 |
| 09:34 ET | 500 | 272.9601 |
| 09:38 ET | 300 | 276.24 |
| 09:39 ET | 800 | 276.24 |
| 09:41 ET | 400 | 276.93 |
| 09:43 ET | 300 | 277.2 |
| 09:45 ET | 500 | 277.19 |
| 09:48 ET | 100 | 276.98 |
| 09:50 ET | 200 | 276.99 |
| 09:52 ET | 400 | 276.74 |
| 09:54 ET | 1204 | 275.775 |
| 09:56 ET | 400 | 276.46 |
| 09:57 ET | 800 | 276.04 |
| 09:59 ET | 347 | 276.5 |
| 10:01 ET | 700 | 276.16 |
| 10:06 ET | 1513 | 276.36 |
| 10:08 ET | 300 | 276.51 |
| 10:10 ET | 1774 | 276.51 |
| 10:12 ET | 400 | 276.97 |
| 10:14 ET | 400 | 276.96 |
| 10:15 ET | 200 | 276.555 |
| 10:17 ET | 2130 | 276.74 |
| 10:19 ET | 1357 | 276.39 |
| 10:21 ET | 200 | 276.345 |
| 10:24 ET | 200 | 276.38 |
| 10:26 ET | 300 | 276.375 |
| 10:28 ET | 341 | 276.0336 |
| 10:30 ET | 1044 | 275.97 |
| 10:32 ET | 100 | 276.11 |
| 10:33 ET | 653 | 276.28 |
| 10:35 ET | 329 | 276.67 |
| 10:39 ET | 784 | 277.47 |
| 10:44 ET | 900 | 278.34 |
| 10:46 ET | 300 | 278.21 |
| 10:48 ET | 983 | 278.64 |
| 10:50 ET | 1387 | 278.67 |
| 10:51 ET | 400 | 278.91 |
| 10:53 ET | 270 | 279.065 |
| 10:55 ET | 500 | 279.28 |
| 10:57 ET | 300 | 279.42 |
| 11:00 ET | 1143 | 279.18 |
| 11:02 ET | 100 | 279.47 |
| 11:04 ET | 857 | 279.48 |
| 11:06 ET | 515 | 279.48 |
| 11:09 ET | 500 | 279.24 |
| 11:11 ET | 3265 | 278.29 |
| 11:13 ET | 200 | 278.28 |
| 11:15 ET | 200 | 277.6881 |
| 11:18 ET | 200 | 277.68 |
| 11:20 ET | 100 | 277.79 |
| 11:26 ET | 588 | 277.98 |
| 11:27 ET | 1298 | 278.005 |
| 11:29 ET | 203 | 277.83 |
| 11:31 ET | 1412 | 278.19 |
| 11:38 ET | 1000 | 278.59 |
| 11:40 ET | 300 | 278.59 |
| 11:44 ET | 100 | 278.38 |
| 11:45 ET | 500 | 278.37 |
| 11:47 ET | 100 | 278.25 |
| 11:49 ET | 600 | 278.385 |
| 11:51 ET | 1000 | 278.345 |
| 11:54 ET | 1134 | 278.46 |
| 11:56 ET | 100 | 278.28 |
| 12:00 ET | 4405 | 278.02 |
| 12:02 ET | 900 | 278.115 |
| 12:03 ET | 300 | 278.135 |
| 12:05 ET | 100 | 278.34 |
| 12:07 ET | 800 | 278.305 |
| 12:09 ET | 300 | 278.275 |
| 12:16 ET | 1026 | 278.05 |
| 12:21 ET | 100 | 278.085 |
| 12:30 ET | 1191 | 278.36 |
| 12:32 ET | 866 | 278.62 |
| 12:34 ET | 200 | 278.76 |
| 12:36 ET | 1182 | 279 |
| 12:38 ET | 549 | 278.63 |
| 12:39 ET | 527 | 279 |
| 12:41 ET | 797 | 279.05 |
| 12:43 ET | 581 | 279.02 |
| 12:45 ET | 100 | 278.75 |
| 12:48 ET | 506 | 278.62 |
| 12:50 ET | 20558 | 279.02 |
| 12:52 ET | 2370 | 278.99 |
| 12:54 ET | 541 | 278.6 |
| 12:56 ET | 2704 | 279.165 |
| 12:57 ET | 2033 | 279 |
| 01:01 ET | 100 | 278.83 |
| 01:08 ET | 200 | 278.4988 |
| 01:10 ET | 200 | 278.66 |
| 01:12 ET | 163 | 278.64 |
| 01:14 ET | 203 | 278.49 |
| 01:15 ET | 1195 | 278.615 |
| 01:17 ET | 400 | 278.62 |
| 01:19 ET | 1100 | 278.79 |
| 01:21 ET | 100 | 278.76 |
| 01:24 ET | 2737 | 278.47 |
| 01:26 ET | 702 | 278.695 |
| 01:28 ET | 700 | 278.78 |
| 01:30 ET | 400 | 278.76 |
| 01:32 ET | 100 | 278.795 |
| 01:35 ET | 100 | 278.56 |
| 01:37 ET | 600 | 278.445 |
| 01:39 ET | 200 | 278.405 |
| 01:42 ET | 200 | 278.455 |
| 01:44 ET | 500 | 278.22 |
| 01:53 ET | 125 | 278.08 |
| 01:55 ET | 810 | 278.01 |
| 01:57 ET | 314 | 278.04 |
| 02:00 ET | 2082 | 277.99 |
| 02:08 ET | 576 | 278.255 |
| 02:09 ET | 600 | 278.215 |
| 02:13 ET | 100 | 278.23 |
| 02:18 ET | 100 | 278.1425 |
| 02:24 ET | 200 | 278.31 |
| 02:27 ET | 1748 | 278.285 |
| 02:31 ET | 1100 | 278.59 |
| 02:38 ET | 2164 | 278.525 |
| 02:40 ET | 300 | 278.6755 |
| 02:42 ET | 2400 | 278.885 |
| 02:44 ET | 252 | 278.995 |
| 02:45 ET | 1600 | 278.43 |
| 02:47 ET | 980 | 278.215 |
| 02:49 ET | 627 | 278.01 |
| 02:56 ET | 140 | 278.21 |
| 03:00 ET | 100 | 278.03 |
| 03:02 ET | 1600 | 278.05 |
| 03:03 ET | 1663 | 277.535 |
| 03:05 ET | 300 | 277.545 |
| 03:09 ET | 915 | 277.565 |
| 03:12 ET | 455 | 277.55 |
| 03:14 ET | 1377 | 277.32 |
| 03:16 ET | 100 | 277.215 |
| 03:18 ET | 200 | 277.38 |
| 03:20 ET | 100 | 277.45 |
| 03:23 ET | 241 | 277.53 |
| 03:25 ET | 544 | 277.83 |
| 03:32 ET | 1500 | 277.745 |
| 03:34 ET | 1508 | 277.945 |
| 03:36 ET | 821 | 277.98 |
| 03:38 ET | 600 | 277.95 |
| 03:39 ET | 1331 | 277.94 |
| 03:41 ET | 400 | 277.93 |
| 03:43 ET | 3589 | 278.33 |
| 03:45 ET | 1200 | 277.285 |
| 03:48 ET | 2869 | 277.36 |
| 03:50 ET | 1222 | 277.115 |
| 03:52 ET | 4924 | 277.11 |
| 03:54 ET | 3880 | 277.03 |
| 03:56 ET | 3647 | 277.01 |
| 03:57 ET | 2829 | 276.94 |
| 03:59 ET | 62513 | 276.73 |
Today
Jun 3, 2024
*DJ Liquidia District Court Issues Favorable Ruling and Denies United Therapeutics' Request to Block Yutrepia Launch >LQDA, from 7:03AM ET on Monday Jun 03, 2024 by Dow Jones
7:03AM ET on Monday Jun 03, 2024 by Dow Jones
May 21, 2024
DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones
12:23PM ET on Tuesday May 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 12.2B | 13.1x | +8.22% |
Biomarin Pharmaceutical Inc | 14.3B | 75.4x | --- |
Medpace Holdings Inc | 12.0B | 41.6x | +35.10% |
Neurocrine Biosciences Inc | 13.6B | 36.7x | +62.04% |
Beigene Ltd | 16.0B | -21.0x | --- |
Exact Sciences Corp | 8.4B | -34.4x | --- |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.2B |
|---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 13.1x |
Price/Sales (TTM) | 4.9 |
Price/Cash Flow (TTM) | 11.0x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
